US Hospitals Slow to Adopt Newer Antibiotics for Highly Resistant Infections
Hospitals still treated over 40% of patients battling highly resistant infections exclusively with the older, generic agents, an NIH study finds.
Hospitals still treated over 40% of patients battling highly resistant infections exclusively with the older, generic agents, an NIH study finds.
Starting June 1, eligible patients will pay no more than $35 per month for all AstraZeneca US inhaled respiratory medicines.
Two recent studies have found that flu vaccines were effective for all ages against both moderate and severe flu in the US during the 2022-2023 flu season.
Theravance Biopharma's COPD treatment Yupelri was not superior to Boehringer Ingelheim's Spiriva Handihaler, according to results from a phase 4 study reported by Theravance.
Cedars-Sinai investigators suggest it may be helpful to keep an eye on patients with underlying health issues after COVID-19 vaccination to monitor for post-vaccine POTS, a condition that causes an abnormal increase in heart rate after standing or sitting up.
The vaccine was approved for older adults and infants through maternal immunization.